QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.063347v1 309/2/594    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Neuwelt, E. A. Articles by Muldoon, L. L. Search for Related Content PubMed PubMed Citation Articles by Neuwelt, E. A. Articles by Muldoon, L. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETYLCYSTEINE Medline Plus Health Information Brain Cancer

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

Bone Marrow Chemoprotection without Compromise of Chemotherapy Efficacy in a Rat Brain Tumor Model

Departments of Neurology (E.A.N., L.L.M.) and Neurosurgery (E.A.N.), Division of Medical Informatics and Clinical Epidemiology (D.F.K.), and Department of Cell and Developmental Biology (L.L.M.), Oregon Health Sciences University, Portland, Oregon; Veterans Affairs Medical Center (E.A.N., M.A.P.), Portland, Oregon; and Departments of Physiology and Biophysics and Medicine (D.R.P.), Chicago Medical School, North Chicago, Illinois

Thiol chemoprotective agents can reduce chemotherapy side effects, but clinical use is limited due to concerns of impaired chemotherapeutic efficacy. We evaluated whether an optimized bone marrow chemoprotection regimen impaired the efficacy of enhanced chemotherapy against rat brain tumors. Nude rats with intracerebral human lung carcinoma xenografts were treated with carboplatin, melphalan, and etoposide phosphate delivered intra-arterially with osmotic blood-brain barrier disruption (n = 8/group). Thiol chemoprotection was N-acetyl-L-cysteine (1000 mg/kg) 60 min before chemotherapy and/or sodium thiosulfate (8 g/m²) 4 and 8 h after chemotherapy, when the blood-brain barrier is reestablished. Blood counts were obtained before treatment on day 3 and at sacrifice on day 9. N-acetylcysteine serum clearance half-life was 9 to 11 min. Pretreatment with N-acetylcysteine combined with delayed administration of sodium thiosulfate protected against toxicity toward total white cells, granulocytes, and platelets (P = 0.0016). Enhanced chemotherapy reduced intracerebral tumor volume to 4.3 ± 1.0 mm³ compared with 29.1 ± 4.1 mm³ in untreated animals (P < 0.0001). Tumor volume was 3.7 ± 0.6 mm³ in rats that received N-acetylcysteine before and sodium thiosulfate after chemotherapy. The data indicate the efficacy of enhanced chemotherapy for rat brain tumors was not affected by thiol chemoprotection that provided excellent protection for hematological toxicity. Negative interactions of thiols with antitumor efficacy were avoided by temporal and spatial separation of chemoprotectants and chemotherapy.

Address correspondence to: Dr. Edward A. Neuwelt, Oregon Health and Sciences University, L603, 3181 SW Sam Jackson Park Rd., Portland OR 97239. E-mail: neuwelte{at}ohsu.edu

This article has been cited by other articles:

				K. Jahnke, L. L. Muldoon, C. G. Varallyay, S. J. Lewin, D. F. Kraemer, and E. A. Neuwelt Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model Neuro-oncol, January 1, 2009; 11(2): 142 - 150. [Abstract] [Full Text] [PDF]

				M. E. Jung, J. W. Simpkins, A. M. Wilson, H. F. Downey, and R. T. Mallet Intermittent hypoxia conditioning prevents behavioral deficit and brain oxidative stress in ethanol-withdrawn rats J Appl Physiol, August 1, 2008; 105(2): 510 - 517. [Abstract] [Full Text] [PDF]

				T. M. Harned, O. Kalous, A. Neuwelt, J. Loera, L. Ji, P. Iovine, R. Sposto, E. A. Neuwelt, and C. P. Reynolds Sodium Thiosulfate Administered Six Hours after Cisplatin Does Not Compromise Antineuroblastoma Activity Clin. Cancer Res., January 15, 2008; 14(2): 533 - 540. [Abstract] [Full Text] [PDF]

				L. L. Muldoon, C. Soussain, K. Jahnke, C. Johanson, T. Siegal, Q. R. Smith, W. A. Hall, K. Hynynen, P. D. Senter, D. M. Peereboom, et al. Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality Check J. Clin. Oncol., June 1, 2007; 25(16): 2295 - 2305. [Abstract] [Full Text] [PDF]

				J. H. Doroshow Redox modulation of chemotherapy-induced tumor cell killing and normal tissue toxicity. J Natl Cancer Inst, February 15, 2006; 98(4): 223 - 225. [Full Text] [PDF]

				K. R. G. Knight, D. F. Kraemer, and E. A. Neuwelt Ototoxicity in Children Receiving Platinum Chemotherapy: Underestimating a Commonly Occurring Toxicity That May Influence Academic and Social Development J. Clin. Oncol., December 1, 2005; 23(34): 8588 - 8596. [Abstract] [Full Text] [PDF]

				D. T. Dickey, Y. J. Wu, L. L. Muldoon, and E. A. Neuwelt Protection against Cisplatin-Induced Toxicities by N-Acetylcysteine and Sodium Thiosulfate as Assessed at the Molecular, Cellular, and in Vivo Levels J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1052 - 1058. [Abstract] [Full Text] [PDF]

				Y. J. Wu, L. L. Muldoon, and E. A. Neuwelt The Chemoprotective Agent N-Acetylcysteine Blocks Cisplatin-Induced Apoptosis through Caspase Signaling Pathway J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 424 - 431. [Abstract] [Full Text] [PDF]

				N. D. Doolittle, L. E. Abrey, W. A. Bleyer, S. Brem, T. P. Davis, P. Dore-Duffy, L. R. Drewes, W. A. Hall, J. M. Hoffman, A. Korfel, et al. New Frontiers in Translational Research in Neuro-oncology and the Blood-Brain Barrier: Report of the Tenth Annual Blood-Brain Barrier Disruption Consortium Meeting Clin. Cancer Res., January 15, 2005; 11(2): 421 - 428. [Abstract] [Full Text] [PDF]